SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-011591
Filing Date
2023-04-03
Accepted
2023-04-03 16:15:47
Documents
14
Period of Report
2023-04-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hsto-20230403.htm   iXBRL 8-K 69720
2 EX-99.1 hsto-ex99_1.htm EX-99 23899
3 GRAPHIC img196544735_0.jpg GRAPHIC 2092
  Complete submission text file 0000950170-23-011591.txt   226690

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hsto-20230403_pre.xml EX-101.PRE 11118
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hsto-20230403.xsd EX-101.SCH 2474
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hsto-20230403_lab.xml EX-101.LAB 17752
8 EXTRACTED XBRL INSTANCE DOCUMENT hsto-20230403_htm.xml XML 4699
Mailing Address 10655 SORRENTO VALLEY ROAD SUITE 200 San Diego CA 92121
Business Address 10655 SORRENTO VALLEY ROAD SUITE 200 San Diego CA 92121 (858) 526-3100
Histogen Inc. (Filer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36003 | Film No.: 23792807
SIC: 2834 Pharmaceutical Preparations